Cargando…

Prevalence of high-risk cardiovascular patients with therapy-resistant hypercholesterolemia

Hypercholesterolemia is a causal risk factor for cardiovascular diseases, which is recommended to be treated at least in high-risk patients. Yet, currently there is a lack of epidemiological data on the number of high-risk patients in Germany who do not respond adequately to high-dose statin monothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kostev, Karel, Parhofer, Klaus G., Dippel, Franz-Werner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427976/ https://www.ncbi.nlm.nih.gov/pubmed/28540139 http://dx.doi.org/10.1097/XCE.0000000000000098

Ejemplares similares

Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
por: Kostev, Karel, et al.
Publicado: (2015)

Risk of hypoglycaemia in type 2 diabetes patients under different insulin regimens: a primary care database analysis
por: Kostev, Karel, et al.
Publicado: (2015)

Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia
por: Parhofer, Klaus G
Publicado: (2012)

Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia
por: Parhofer, Klaus G
Publicado: (2009)

Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia
por: Gitt, Anselm K., et al.
Publicado: (2022)

Estimating Prevalence and Characteristics of Statin Intolerance among High and Very High Cardiovascular Risk Patients in Germany (2017 to 2020)
por: Parhofer, Klaus G., et al.
Publicado: (2023)

Prevalence of Cardiovascular Disease Risk Factors in Migrants Participating in the PEP Family Heart Study, Nuremberg
por: Haas, Gerda-Maria, et al.
Publicado: (2010)

Estimating prevalence and characteristics of statin intolerance among high and very high cardiovascular risk patients in Germany between 2017–2020
por: Parhofer, K G, et al.
Publicado: (2022)

Polygenic Hypercholesterolemia and Cardiovascular Disease Risk
por: Sharifi, Mahtab, et al.
Publicado: (2019)

Conflicts at work are associated with a higher risk of cardiovascular disease
por: Jacob, Louis, et al.
Publicado: (2017)

Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain
por: de la Sierra, Alex, et al.
Publicado: (2015)

Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
por: Boutari, Chrysoula, et al.
Publicado: (2022)

Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk
por: Agabiti Rosei, Enrico, et al.
Publicado: (2016)

Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care
por: Pscherer, S, et al.
Publicado: (2016)

Correlation of cardiovascular risk predictors with overweight and obesity in patients with familial hypercholesterolemia
por: Wang, Yaodong, et al.
Publicado: (2022)

Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study
por: Nam, Chang-Wook, et al.
Publicado: (2019)

Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics
por: Lee, Sang-Hak
Publicado: (2017)

Clinical benefit of long-term lipoprotein apheresis in patients with severe hypercholesterolemia or Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease
por: Heigl, Franz, et al.
Publicado: (2015)

Prevalence of chronic diseases among older patients in German general practices
por: Jacob, Louis, et al.
Publicado: (2016)

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
por: Sudano, Isabella, et al.
Publicado: (2022)

Prevalence of Spirometry Testing among Patients with Asthma and COPD in German General Practices
por: Härtel, Annika, et al.
Publicado: (2022)

Prevalence and Treatment of Familial Hypercholesterolemia and Severe Hypercholesterolemia in Older Adults in Ontario, Canada
por: Akioyamen, Leo E., et al.
Publicado: (2022)

Prediction of Familial Hypercholesterolemia in Patients at High Atherosclerotic Cardiovascular Disease Risk Using a Recently Validated Algorithm
por: Alothman, Latifah, et al.
Publicado: (2019)

Risk of cardiovascular disease with lipoprotein(a) in familial hypercholesterolemia: a review
por: Watanabe, Jun, et al.
Publicado: (2020)

Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease
por: Trinder, Mark, et al.
Publicado: (2020)

Impact of Severe Hypercholesterolemia on Cardiovascular Risk in Individuals With or Without Diabetes Mellitus
por: Lee, Chan Joo, et al.
Publicado: (2022)

Familial Hypercholesterolemia Genetic Variations and Long-Term Cardiovascular Outcomes in Patients with Hypercholesterolemia Who Underwent Coronary Angiography
por: Lee, Wen-Jane, et al.
Publicado: (2021)

Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy
por: Vuorio, Alpo, et al.
Publicado: (2022)

Germany Endometriosis Pattern Changes; Prevalence and Therapy over 2010 and 2019 Years: A Retrospective Cross- Sectional Study
por: Göhring, Jacob, et al.
Publicado: (2022)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022)

Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction
por: Cui, Yuxia, et al.
Publicado: (2019)

Prevalence of depression, anxiety, adjustment disorders, and somatoform disorders in patients with age-related macular degeneration in Germany
por: Jacob, Louis, et al.
Publicado: (2017)

Prevalence of and Factors Associated with Antibiotic Prescriptions in Patients with Acute Lower and Upper Respiratory Tract Infections—A Case-Control Study
por: Kern, Winfried V., et al.
Publicado: (2021)

Phytosterols in the Treatment of Hypercholesterolemia and Prevention of Cardiovascular Diseases
por: Cabral, Carlos Eduardo, et al.
Publicado: (2017)

Comment on Mizokami-Stout et al. The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange. Diabetes Care 2020;43:806–812
por: Kostev, Karel
Publicado: (2020)

Hypercholesterolemia Causes Circadian Dysfunction: A Potential Risk Factor for Cardiovascular Disease
por: Akashi, Makoto, et al.
Publicado: (2017)

Cardiorespiratory Fitness and the Risk of All-Cause, Cardiovascular and Cancer Mortality in Men with Hypercholesterolemia
por: Sui, Xuemei, et al.
Publicado: (2022)

Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia
por: Berta, Eszter, et al.
Publicado: (2022)

Cardiovascular Risk and Treatment Outcomes in Severe Hypercholesterolemia: A Nationwide Cohort Study
por: Lee, Chan Joo, et al.
Publicado: (2022)

Evaluation of cardiovascular risk factors in patients with familial hypercholesterolemia from the North-Eastern area of Romania
por: Vlad, Cristiana-Elena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gals3e53uae2jude0hjrn49jua